Back to Search

BRUCE YACYSHYN, MD

MD

Gastroenterology Physician

NPI: 1467466771IndividualAccepts Medicare

Specialties, Licenses & Credentials

Gastroenterology PhysicianPrimary

Internal Medicine — Gastroenterology

Code: 207RG0100X

01064973A(IN)R9F93(MO)35.080517(OH)
Internal Medicine Physician

Internal Medicine

Code: 207R00000X

35.080517(OH)

CMS Specialties

PrimaryGASTROENTEROLOGY

Education

UNIVERSITY OF ALBERTA FACULTY OF DENTISTRY

Class of 1982

Clinical Trials (1)

1
Linked Trials
0
Recruiting
1
With Results

Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol)

NCT04811339COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (16)

Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy.
PMID 35370296·Curr Ther Res Clin Exp·2022
8-other
Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea.
PMID 32772204·Dig Dis Sci·2021
1-meta
Adhesion molecule therapeutics in IBD.
PMID 18816743·Inflamm Bowel Dis·2008
8-other
Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM-1.
PMID 15958080·Clin Exp Immunol·2005
3-trial
Antisense oligonucleotide treatment of inflammatory bowel diseases.
PMID 15375323·Methods Mol Med·2005
6-review
Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial.
PMID 18080055·Can J Gastroenterol·2007
4-observational
A randomized, double-masked, placebo-controlled study of alicaforsen, an antisense inhibitor of intercellular adhesion molecule 1, for the treatment of subjects with active Crohn's disease.
PMID 17296530·Clin Gastroenterol Hepatol·2007
4-observational
Prevalence of occult gastrointestinal bleeding in celiac disease.
PMID 16616349·Clin Gastroenterol Hepatol·2006
8-other
Discussion on the safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study.
PMID 14628819·Gastroenterology·2003
8-other
The clinical importance of proton pump inhibitor pharmacokinetics.
PMID 12428065·Digestion·2002
6-review
Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease.
PMID 12269969·Aliment Pharmacol Ther·2002
3-trial
Amelioration of chronic and spontaneous intestinal inflammation with an antisense oligonucleotide (ISIS 9125) to intracellular adhesion molecule-1 in the HLA-B27/beta2 microglobulin transgenic rat model.
PMID 12183646·J Pharmacol Exp Ther·2002
7-preclinical
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease.
PMID 12077088·Gut·2002
3-trial
The concept and application of antisense oligonucleotides.
PMID 11584192·Dis Colon Rectum·2001
8-other
Critical review of acid suppression in nonvariceal, acute, uppergastrointestinal bleeding.
PMID 11279330·Dig Dis·2000
6-review
Alterations in protein kinase C isoforms in experimentally-induced colitis in the rat.
PMID 10778918·Inflamm Res·2000
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 3 locations total

Address
7700 WASHINGTON VILLAGE DR STE 120
CENTERVILLE, OH 45459

Locations (3)

Practice Location

7700 WASHINGTON VILLAGE DR STE 120, CENTERVILLE, OH
(937) 425-4144

Practice Location

222 PIEDMONT AVE, CINCINNATI, OH
(513) 475-7505

Practice Location

1402 E COUNTY LINE RD, INDIANAPOLIS, IN
(317) 887-7000

Quick Facts

NPI
1467466771
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
4
Locations
3
Years in Practice
44
Clinical Trials
1
Publications
16

Are you this provider?

Claim Your Profile